NdPr is still failing and not looking well, there is excessive inventory and a weak outlook. How about they focus on one thing stop spending unnecessary money. They are burning through the cash and will need money soon when at the time prices are depressed.
- Forums
- ASX - By Stock
- Ann: Phosphate Bioavailability Test Results
NdPr is still failing and not looking well, there is excessive...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEK (ASX) to my watchlist
|
|||||
Last
21.5¢ |
Change
0.010(4.88%) |
Mkt cap ! $57.17M |
Open | High | Low | Value | Volume |
20.5¢ | 21.5¢ | 20.5¢ | $21.48K | 103.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 70478 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 51024 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70478 | 0.200 |
2 | 102539 | 0.195 |
7 | 421608 | 0.190 |
5 | 580563 | 0.185 |
8 | 446884 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 51024 | 2 |
0.220 | 1068 | 1 |
0.230 | 13297 | 1 |
0.235 | 179596 | 2 |
0.240 | 27500 | 2 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online